Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations

Leuk Res. 2007 Jul;31(7):1009-14. doi: 10.1016/j.leukres.2006.11.014. Epub 2007 Jan 3.

Abstract

We report a JAK2 V617F-negative case of polycythemia vera with two acquired balanced X-autosome translocations and no history of previous exposure to chemo/radiotherapy. The patient's first clone carried a novel translocation t(X;15)(q24;q13) as a sole abnormality. The second clone exhibited an additional translocation, t(X;20)(q13;q13.3), which is a rare recurrent abnormality in myeloid malignancies. This is the first report of a hematological disorder with both X chromosomes being translocated. Late replication studies revealed a switch in X-inactivation from the X chromosome involved in t(X;15) (first clone) to the X chromosome involved in the t(X;20)(q13;q13.3) (second clone). The inactivation of the translocated X chromosomes could provide potential for the inactivation of the adjacent autosomal regions, resulting in epigenetic gene silencing.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Chromosome Disorders / complications
  • Chromosome Disorders / genetics*
  • Chromosomes, Human, Pair 5 / genetics*
  • Chromosomes, Human, X / genetics*
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Janus Kinase 2 / genetics*
  • Polycythemia Vera / genetics*
  • Translocation, Genetic*
  • X Chromosome Inactivation / genetics*

Substances

  • JAK2 protein, human
  • Janus Kinase 2